Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin PK/PD in Pediatric Dengue
NCT03432442Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Sep 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ivermectin in dengue hemorrhagic fever (DHF) (4 arms), sponsored by Mahidol University. Primary endpoint: Pharmacokinetics of ivermectin at 7 days. Started Sep 2018; status: completed.
02
Drugs
ivermectin
03
Conditions
dengue hemorrhagic fever (DHF)
Beyond the preview
Go deeper on NCT03432442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432442.